Non–Small Cell Lung Cancer, Version 6.2015

Cited by (479)

Items 301–400 of 479

1. Spatiotemporal Concurrent PARP Inhibitor Sensitization Based on Radiation‐Responsive Nanovesicles for Lung Cancer Chemoradiotherapy
   Fei Kang, Meng Niu, Zijian Zhou, Mingru Zhang, Hehe Xiong, Fantian Zeng, Jing Wang, Xiaoyuan Shawn Chen · 2024 · Advanced Healthcare Materials
2. CYP3A4 genetic variants are associated with susceptibility of non-small cell lung cancer in a Shaanxi Han population
   Zhuoqi Jia, Weiru Zhou, Guangjian Zhang, Junke Fu, Daxu Li, Le Ren · 2020 · Genomics
3. Computed tomography-guided cutting needle biopsy for lung nodules
   Huimei Zhang, Xiao-Bing Huo, Hua-Long Wang, Zhang Xiao, Yu‐Fei Fu · 2021 · Medicine
4. Machine Learning for the Prediction of Lymph Nodes Micrometastasis in Patients with Non-Small Cell Lung Cancer: A Comparative Analysis of Two Practical Prediction Models for Gross Target Volume Delineation
   Shuli Hu, Man Luo, Yaling Li · 2021 · Cancer Management and Research
5. PELP1 is overexpressed in lung cancer and promotes tumor cell malignancy and resistance to tyrosine kinase inhibitor drug
   Xingen Wang, Weihua Yin, Li Liang · 2022 · Pathology - Research and Practice
6. Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine
   Radosław Mlak, Paweł Adam Krawczyk, Marzanna Ciesielka, Iwona Homa‐Mlak, Tomasz Powrózek, Monika Prendecka, Piotr Kozioł, Janusz Milanowski, Teresa J Malecka-Massalska · 2015 · Cancer Chemotherapy and Pharmacology
7. Factors Influencing the Diagnostic Accuracy of Identifying the Histologic Type of Non–Small-Lung Cancer With Small Samples
   Takefumi Oikawa, Tatsuo Ohira, Jun Matsubayashi, Chimori Konaka, Norihiko Ikeda · 2015 · Clinical Lung Cancer
8. Video-assisted thoracoscopic surgery lobectomy with chest wall resection
   Guilherme Dal Agnol, Ricardo Oliveira, Paula Antonia Ugalde · 2018 · Journal of Thoracic Disease
9. Human Bronchial Epithelial Cells Induce CD141/CD123/DC-SIGN/FLT3 Monocytes That Promote Allogeneic Th17 Differentiation
   Amiq Gazdhar, Fabian Blank, Valérie Cesson, Alban Lovis, John‐David Aubert, Romain Lazor, François Spertini, Anne Wilson, Katrin Hostettler, Laurent Pierre Nicod et al. · 2017 · Frontiers in Immunology
10. Epidermal growth factor receptor T790M mutation: A major culprit in the progression of epidermal growth factor receptor-driven non-small cell lung cancer and the role of repeat biopsy
    Shyam Aggarwal, S Patil, Nitesh Rohtagi · 2017 · Indian Journal of Cancer
11. Safety Profile and Hepatotoxicity of Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: A Disproportionality Analysis Based on FDA Adverse Event Reporting System Database
    Yun Yang, Shiyi Tan, Yuepu Pu, Juan Zhang · 2025 · Toxics
12. Clinically significant mutations in HIV-infected patients with lung adenocarcinoma
    Jonathan Thaler, Carlie Sigel, Mary Beth Beasley, Juan Pablo Wisnivesky, Kristina A. Crothers, Joshua Michael Bauml, Kristen M. Hysell, Brinda Emu, Laetitia A Borsu, Keith Magnus Sigel · 2017 · British Journal of Cancer
13. Integrated histological and molecular analyses of rebiopsy samples at osimertinib progression improve post-progression survivals: A single-center retrospective study
    Jiangtao Cheng, Yihui Yao, Yu-Er Gao, Shiling Zhang, Hua‐Jun Chen, Zhen Wang, Hong‐Hong Yan, Qing Hua Zhou, Hai‐Yan Tu, Xu‐Chao Zhang et al. · 2020 · Lung Cancer
14. Combination of serum ACSL4 levels and low-dose 256-slice spiral CT exhibits the potential in the early screening of lung cancer
    Wenlong Yu, Li Wang, Shi Liu, Ying Liu, Shuying Wang, Xuejia Sun · 2023 · Medicine
15. Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor
    Wenxian Wang, Xiaowen Jiang, Zhengbo Song, Yiping Zhang · 2016 · OncoTargets and Therapy
16. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists
    Shaan Dudani, Natasha B. Leighl, Cheryl Ho, Jason R. Pantarotto, Xiaofu Zhu, Tinghua Zhang, Paul Wheatley‐Price · 2016 · Lung Cancer
17. Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention
    Chia‐Cheng Tseng, Chin‐Chou Wang, Chang‐Chun Hsiao, Hung‐I Lu, Steve Leu, Huang‐Chih Chang, Kuo‐Tung Huang, Wen‐Feng Fang, Yu‐Mu Chen, Shih‐Feng Liu et al. · 2016 · Tumor Biology
18. Prognostic values of various hematological variables as markers of systemic inflammation in metastatic lung cancer
    S. Seber, Duygu Bayır, Tarkan Yetişyiğit · 2018 · Journal of Cancer Research and Therapeutics
19. Low dose of apatinib in treating chemotherapy and EGFR-TKI refractory non-small cell lung cancer
    Jin Liu, Yulong Zheng, Nong Xu · 2019 · Medicine
20. Results of liquid biopsy studies by next generation sequencing in patients with advanced stage non-small cell lung cancer: Single center experience from Turkey
    Mahmut Büyükşimşek, Mustafa TOĞUN, Kara I Oguz, Atıl Bişgin, İbrahım Boğa, Mert Tohumcuoğlu, Ali Oğul, Abdullah Evren Yetişir, B. Şahin, Hilmi Erdem Sümbül et al. · 2019 · Balkan Journal of Medical Genetics
21. Target-based genomic profiling of ctDNA from Chinese non-small cell lung cancer patients: a result of real-world data
    Huijuan Chen, Aiqin Wang, Jing Wang, HE Ze-ming, Yanqiu Mao, Liming Liu · 2020 · Journal of Cancer Research and Clinical Oncology
22. Identification and analysis of genes associated with lung adenocarcinoma by integrated bioinformatics methods
    Hui Xie, Jian‐Fang Zhang, Qing Li · 2021 · Annals of Human Genetics
23. Efficacy and Safety of Addition of Anti-PD1 to Chemotherapy in Treatment of Non-Small Cell Lung Cancer
    Chuhui Ru, Yan-Bing Zhuang · 2019 · Combinatorial Chemistry & High Throughput Screening
24. The ‘Liaisons dangereuses’ Between Lung Cancer and Interstitial Lung Diseases: A Focus on Acute Exacerbation
    Umberto Zanini, Paola Faverio, Valentina Bonfanti, Maria Falzone, Diego Luigi Cortinovis, Stefano Arcangeli, Francesco Petrella, Giovanni Ferrara, Marco Mura, Fabrizio Luppi · 2024 · Journal of Clinical Medicine
25. Overexpression of ecotropic viral integration site-1 is a prognostic factor of lung squamous cell cancer
    Xueliang Xu, Shengchen Liu, Xia Ji · 2017 · OncoTargets and Therapy
26. Treatment Response To Osimertinib In EGFR-Mutated Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Series
    Huiying Li, Tingting Yu, Mingmin Huang, Aibin Guo, Xiaoping Qian, Zhenyu Yin · 2019 · OncoTargets and Therapy
27. A multi-institutional randomized phase III trial comparing postoperative radiotherapy to observation after adjuvant chemotherapy in patients with pathological N2 Stage III non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1916 (J-PORT study)
    Ryo Shimoyama, Kazuo Nakagawa, Satoshi Ishikura, Masashi Wakabayashi, Tomonari Sasaki, Hiroshige Yoshioka, Tadayoshi Hashimoto, Tomoko Kataoka, Haruhiko Fukuda, Shun-ichi J. WATANABE · 2021 · Japanese Journal of Clinical Oncology
28. Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting
    Manglio Rizzo, Maria Virginia Bluthgen, Gonzalo Recondo, Martin Naveira, Aldo Perfetti, Florencia Rizzi, Alejandro Kuzminin, Victoria Faura, M. Cerini, Alejandro J. Videla et al. · 2021 · International Journal of Clinical Oncology
29. Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study
    Jie Zhang, Di Wu, Ziran Zhang, Jieran Long, Guangming Tian, Yang Wang, Xiangjuan Ma, Xiaoling Chen, Jindi Han, Weiheng Hu et al. · 2021 · Technology in Cancer Research & Treatment
30. Modelled Economic Analysis for Dacomitinib–A Cost Effectiveness Analysis in Treating Patients With EGFR-Mutation-Positive Non-Small Cell Lung Cancer in China
    Yongfeng Yu, Luan Luan, Fan-fan Zhu, Peng Dong, Liheng Ma, Lanting Li, Lan Gao, Shun Lü · 2021 · Frontiers in Oncology
31. Primary pulmonary adenocarcinoma in a 16-year-old boy – a five-year follow-up
    Ane Stillits Måreng, Seppo Wang Langer, Uffe Christian Steinholtz Bødtger · 2016 · European Clinical Respiratory Journal
32. Propensity score adjusted analysis of patients with isolated locoregional recurrence versus de novo locally advanced NSCLC treated with definitive therapy
    Cole Friedes, Nicholas Mai, Wei Fu, Chen Hu, Peijin Han, Kristen Ashley Marrone, Khinh Ranh Voong, Russell Kenneth Hales · 2020 · Lung Cancer
33. A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914
    Ryo Shimoyama, Shota Omori, Shogo Nomura, Hirotsugu Kenmotsu, Toshiaki Takahashi, Hideyuki Harada, Satoshi Ishikura, Tomonori Mizutani, Masahiko Ando, Tomoko Kataoka et al. · 2021 · Japanese Journal of Clinical Oncology
34. Practical Value of Molecular Pathology in Stage I–III Lung Cancer: Implications for the Clinical Surgeon
    Christopher G. Azzoli · 2015 · Annals of Surgical Oncology
35. Cirugía torácica video-asistida y resecciones pulmonares anatómicas. ¿Dónde estamos? Encuesta nacional de la Sociedad Española de Cirugía Torácica
    Raúl Embún Flor, Néstor J. Martínez Hernández, Sergi Call, Beatriz de Olaiz Navarro, Jon Zabaleta, Ricard Ramos, Jose Marcelo Galbis, Nicolás Moreno‐Mata · 2016 · Cirugía Española
36. Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis
    Huali Liu, Guang Han, Min Peng, Yi-ming Weng, Jingping Yuan, Guifang Yang, Jinming Yu, Qibin Song · 2017 · Current Medical Science
37. The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells
    Wenchang Feng, Yi Ting, Xing Tang, Dan Liu, Wenchao Zhou, Yukun Li, Zhenyu Shen · 2024 · Heliyon
38. Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in Non–Small-Cell Lung Cancer Patients With an EGFR Mutation
    Shinko Sadoyama, Akimasa Sekine, Hiroaki Satoh, Tae Iwasawa, Terufumi Kato, Satoshi Ikeda, Masafumi Sata, Tomohisa Baba, Erina Tabata, Yuko Minami et al. · 2017 · Clinical Lung Cancer
39. Effects of okadaic acid and hematein on human lung adenocarcinoma A549 cells and responses of mitochondria and endoplasmic reticulum apoptosis pathways
    Renjun Wang, Jiali Wang, Ning Ding, Shanshan He, Yunfeng Zhao, Peike Gao · 2019 · Translational Cancer Research
40. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
    Javier Aragón, Itzell Perez, Diego González-Rivas · 2015 · PubMed Central
41. Maintenance Therapy for Colorectal Cancer: Which Regimen and Which Patients?
    Sameh Mikhail, Tanios Bekaii‐Saab · 2015 · Drugs
42. Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma
    Yuki Matsumura, Yuki Owada, Takuya Inoue, Yuzuru Watanabe, Takumi Yamaura, Mitsuro Fukuhara, Satoshi Muto, Naoyuki Okabe, Takeo Hasegawa, Mika Hoshino et al. · 2017 · Interactive Cardiovascular and Thoracic Surgery
43. Pulmonary Adenocarcinoma—Pathology and Molecular Testing
    Prodipto Pal, Michael Cabanero, Ming‐Sound Tsao · 2018 · Elsevier eBooks
44. AMP‑activated protein kinase α1 serves a carcinogenic role via regulation of vascular endothelial growth factor expression in patients with non‑small cell lung cancer
    Gong Hui, Wang Xiu, Yong Chen, Chi Yuan, Zhang Jun, Jun Gu, Jun Yang, Xu Xiang, Hu Wei, Min Feng · 2019 · Oncology Letters
45. The value of human epididymis protein 4 (HE4) as a serum tumor marker for accurate bone metastases finding by whole-body bone scintigraphy in lung cancer patients
    Jaroslav Weissensteiner, Eva Babušíková · 2019 · Neoplasma
46. Hypofractionation and Stereotactic Body Radiation Therapy in Inoperable Locally Advanced Non-small Cell Lung Cancer
    Mikel Rico, Maribel Martínez, M.C. Rubio Rodríguez, Lombardo Rosas, Andrea Barco, Enrique C. Martinez · 2021 · Journal of Clinical and Translational Research
47. New discoveries in the molecular landscape of bladder cancer
    Roger Li, Woonyoung Choi, James E. Ferguson, Michael Metcalfe, Ashish M. Kamat · 2016 · F1000Research
48. Radical Treatment of Stage II Non–small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes
    Shaan Dudani, Xiaofu Zhu, Daniel W. Yokom, Andrew Yamada, Cheryl Ho, Jason R. Pantarotto, Natasha B. Leighl, Tinghua Zhang, Paul Wheatley‐Price · 2017 · Clinical Lung Cancer
49. Getting out of a wheelchair: an uncommon insertion mutation in exon 19 of EGFR responsive to erlotinib
    Abed Agbarya, Meira Melamed‐Frank, Orit Kaidar‐Person, Ilana Goldberg-Cohen, Haitam Nasrallah, Mira Wollner, Jair Bar, Gad Rennert, Flavio Lejbkowicz · 2014 · SpringerPlus
50. Identification of key immune cells infiltrated in lung adenocarcinoma microenvironment and their related long noncoding RNA
    Kai Wang, Tao Yan, Deyu Guo, Shijie Sun, Yong Liu, Qiang Liu, Guanghui Wang, Jingyu Chen, Jiajun Du · 2024 · iScience
51. Pros: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with large volume unresectable stage III non-small cell lung cancer
    B.M. Rabatic, Feng‐Ming Kong · 2016 · Translational Lung Cancer Research
52. We should be done in such a way that patients with stage IV non-small cell lung cancer who would benefit from surgery are not overlooked
    Yasuhiro Chikaishi, Ayako Hirai, Naoko Imanishi, Yoshinobu Ichiki, Fumihiro Tanaka · 2018 · Journal of Thoracic Disease
53. Thoracic positron emission tomography: 18F-fluorodeoxyglucose and beyond
    Timothy J. Jaykel, Michael S. Clark, Daniel A. Adamo, Brain T. Welch, Scott M. Thompson, Jason R. Young, Eric C. Ehman · 2020 · Journal of Thoracic Disease
54. Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events
    Jessica M. Logan, Doug A. Brooks, Andrew Rowland, Michael Joseph Sorich, Ashley Mark Hopkins · 2021 · Journal of Oncology
55. Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer
    Yunxiang Tang, Ruike Zhang, Yinan Li, Shuyu Xu, Hao Wang, Jingzhou Xu, Lei Xiao, Yajing Wang, Jing Du, Yujia Huang et al. · 2021 · BMC Cancer
56. Significance of detecting the levels of miR-29a, survivin and interferon gamma release assay in patients with lung cancer and tuberculosis
    Lijuan Sun, Hongyun Li, Qun Fu, Shuangmin Hu, Wenfei Zhao · 2022 · Advances in Clinical and Experimental Medicine
57. Effect of stereotactic dosimetric end points on overall survival for Stage I non–small cell lung cancer: A critical review
    Kathryn Mulryan, Michelle Leech, Elizabeth Forde · 2015 · Medical dosimetry
58. Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancer
    Ka-Rham Kim, Jung‐Hwan Yoon, Hyun‐Jeong Shim, Jun‐Eul Hwang, Woo‐Kyun Bae, Ik‐Joo Chung, Hee Nam Kim, Min‐Ho Shin, Sang‐Hee Cho · 2017 · Oncology Letters
59. The role for chemotherapy in 80 years and older patients with metastatic non-small cell lung cancer: A National cancer database analysis
    Zaheer Ahmed, Kevin F. Kennedy, Janakiraman Subramanian · 2021 · Lung Cancer
60. Efficacy and Benefit of Postoperative Chemotherapy in Micropapillray or Solid Predominant Pattern in Stage IB Lung Adenocarcinoma: A Systematic Review and Meta-Analysis
    Congcong Xu, Kanghao Zhu, Dong Chen, Yuhang Ruan, Zixian Jin, Hongbin Qiu, Baofu Chen, Jianfei Shen · 2021 · Frontiers in Surgery
61. Combination of multiple gene markers to detect circulating tumor cells in the peripheral blood of patients with non-small cell lung cancer using real-time PCR
    M. Ding, Xiaogang Li, T. Qiu · 2015 · Genetics and Molecular Research
62. A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report
    Jumpei Kashima, Yusuke Okuma, Tsunekazu Hishima · 2016 · OncoTargets and Therapy
63. Meta-analysis of pemetrexed plus carboplatin doublet safety profile in first-line non-squamous non-small cell lung cancer studies
    Isamu Okamoto, Wolfgang Schuette, Thomas E. Stinchcombe, José Rodrigues Pereira, Belén San Antonio, Jian Chen, Jingyi Liu, William J. John, Ralph Zinner · 2017 · Current Medical Research and Opinion
64. Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma
    Xiaoyu Zhai, Qiwen Zheng, Lu Yang, Yixiang Zhu, Junling Li, Yutao Liu, Ziping Wang · 2017 · Scientific Reports
65. Patterns and Yearly Time Trends in the Use of Radiation Therapy During the Last 30 Days of Life Among Patients With Metastatic Rectal Cancer in the United States From 2004 to 2012
    Adan Z. Becerra, Christian P. Probst, Fergal J. Fleming, Zhaomin Xu, Christopher Thomas Aquina, Carla Francesca Justiniano, Courtney I. Boodry, Alex A. Swanger, Katia Noyes, Alan W. Katz et al. · 2017 · American Journal of Hospice and Palliative Medicine®
66. Technical Requirements for Lung Cancer Radiotherapy
    Fiona Hegi‐Johnson, Todd F. Atwood, Paul Keall, Billy W. Loo · 2018 · Elsevier eBooks
67. [To Explore Clinical Value of Single-port Video-assisted Thoracoscopic Surgery in Elderly Patients with Non-small Cell Lung Cancer: Lobectomy, Segmentectomy and Lobectomy vs Segmentectomy].
    Lin Huang, Bin Zheng, Chun Chen, Wei Zheng, Yong Zhu, Chaohui Guo · 2018 · Europe PMC (PubMed Central)
68. Survival Prediction and Adjuvant Chemotherapy Based on Tumor Marker for Stage IB Lung Adenocarcinoma
    Yiyang Wang, Difan Zheng, Tianxiang Chen, Jie Zhang, Feng Yao, Haiquan Chen · 2019 · The Annals of Thoracic Surgery
69. Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415)
    Farastuk Bozorgmehr, Inn Chung, Jürgen R. Fischer, Marc Bischof, Akin Atmaca, S. Husson Wetzel, Martin Faehling, Dirk Bottke, Martin Wermke, Esther G.C. Troost et al. · 2025 · Clinical & Experimental Metastasis
70. Cuproptosis in lung cancer: a nexus of ncRNA regulation, epigenetics, and tumor microenvironment Remodeling
    Mohamed Soliman Imam, Randa M. Abdel‐Sattar, Nasser M. Aldekhail, Norah Khalid Abdullah Humaish, Shoug Abdulaziz Gary Gary, Mansour Abdulrahman Mansour Alkhulaifi, Misk Abdullah Mohammed Alqahtani, Malak Lafi Zaid Aldajani, Hasna Mohammed Jarallah Altuwayhir, Wasan Izzualdien Abdulrahman Alnaim et al. · 2025 · Clinical and Experimental Medicine
71. Epidermal growth factor receptor ( EGFR )‐tyrosine kinase inhibitors combined with chemotherapy in first‐line treatment in an advanced non‐small cell lung cancer patient with EGFR sensitive mutation
    Aimi Huang, Rong Li, Jikai Zhao, Xiaofei Wang, Bo Jin, Yanjie Niu, Jie Zhang, Liyan Jiang, Baohui Han · 2016 · Thoracic Cancer
72. Upfront Brain Treatments Followed by Lung Surgery Improves Survival for Stage IV Non-small Cell Lung Cancer Patients With Brain Metastases: A Large Cohort Analysis
    Xiaopeng He, Yin Shen, Hongyu Liu, Rong Lü, Kemp H. Kernstine, David E. Gerber, Yang Xie, Donghan M. Yang · 2021 · Frontiers in Surgery
73. Diagnostic value of microRNA-148/152 family in non-small-cell lung cancer (NSCLC)
    Long Cheng, Qinyun Li, Bangxian Tan, Daiyuan Ma, Guobo Du · 2021 · Medicine
74. Oxyresveratrol Inhibits the Growth of Human Lung Squamous Cell Carcinoma Cells by Triggering S-phase Arrest and Apoptosis
    Cheng-Hsuan Chuang, Kok‐Tong Tan, Yu‐Tang Tung, Chi‐Chen Lin · 2019 · Journal of Food Bioactives
75. The prognostic effect of metastasis patterns on overall survival in organ metastatic lung adenocarcinoma
    Xiaowei Tie, Jin Wang, Yong Wang, Baobao Fu, Chenchen Wang, Xiaomin Li, Qianqian Jia, Fang Wang, Simeng Chen, Yanshun Zhang · 2023 · Medicine
76. Identification and validation of the model consisting of DDX49 , EGFR, and T‐stage as a possible risk factor for lymph node metastasis in patients with lung cancer
    Zhimin Zhang, Xiaojuan Lian, Hongxu Yue, Debing Xiang, Zhongxi Niu · 2023 · Thoracic Cancer
77. Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report
    Qicheng Zhang, Peng Ping Xie, Xiaoming Hou, Chengpeng Zhao, Ling Duan, Hui Qiao · 2023 · Journal of Chemotherapy
78. Critical timing: Impact of delays to surgery on prognosis in stage I-II non-small cell lung cancer
    Ye Zhang, Yeji Hu, Jinfeng Xi, Bo Wu, Wenxiong Zhang, Chunling Li · 2025 · PLoS ONE
79. Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy?
    Fiori Alite, Anand Mahadevan · 2020 · Annals of Translational Medicine
80. Which treatment is preferred for advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor in second-line therapy? A meta-analysis comparing immune checkpoint inhibitor, tyrosine kinase inhibitor and chemotherapy
    Di Wu, Chongyang Duan, Fenfang Wu, Liyong Chen, Size Chen · 2017 · Oncotarget
81. Survival of patients with advanced NSCLC treated with first-generation EGFR-TKIs at a cancer hospital in Thailand, 2011-2016.
    Sitthi Sukauichai, Chokaew Tovanabutra, Sirentra Wanglikitkul, Kittisak Chomprasert · 2018
82. Evaluation of Patients with Lung Cancer Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
    Laksmi Wulandari, Anna Febriani, Farah Fatma Wati, Gatot Soegiarto · 2018 · Asian Journal of Oncology
83. Modification of the tumor response threshold in patients of advanced non-small cell lung cancer treated with chemotherapy plus targeted agents: a pooled study from five clinical trials in one institution
    Fan Luo, Zhonghan Zhang, Kunlun Liao, Yang Zhang, Yuxiang Ma, Zhihuang Hu, Kangmei Zeng, Yan Huang, Li Zhang, Hongyun Zhao · 2019 · Annals of Translational Medicine
84. Clonally‐related primary ALK rearranged adenocarcinoma and associated metastatic lesions
    You‐cai Zhu, Yun‐te Deng, Wenxian Wang, C. Xu, Wu Zhuang, Kaiqi Du · 2018 · Thoracic Cancer
85. WITHDRAWN: Prognostic Significance of Programmed Cell Death-Ligand 1 Expression in Patients With Resected Lung Adenocarcinoma
    Jung‐Jyh Hung, Shiu-Feng Kathy Huang, Ying-Ying Shen, Yu–Chung Wu, Teh‐Ying Chou, Wen‐Hu Hsu · 2016 · The Annals of Thoracic Surgery · Retracted
86. Consensus guidelines for thoracic surgical patient management—do they represent the consensus?
    Robert Alexander Meguid · 2019 · Journal of Thoracic Disease
87. Long-term follow-up of a consecutive cohort validating an epidermal growth factor receptor mutation as an independent risk factor for postoperative recurrence in lung adenocarcinoma
    Yuki Matsumura, Kazuki Hayasaka, Tetsuya Ohira, Satoshi Shiono, Jiro Abe, Hirotsugu Notsuda, Akira Sakurada, Hiroyuki Suzuki, Yoshinori Okada · 2023 · Interdisciplinary CardioVascular and Thoracic Surgery
88. Real-World Outcomes of T790M Mutation Testing and Sequential Osimertinib in EGFR-Positive Advanced Non-small Cell Lung Cancer: A Revisited Strategy
    Kelvin Yan, Arizah Bakhtiah, Shweta Hota, Joanne S. Evans, Frankie K. F. Mo · 2025 · Targeted Oncology
89. Comparison of the diagnostic accuracy of [68Ga]Ga-Trivehexin PET/computed tomography and [18F]FDG PET/computed tomography in nodal staging of various solid tumors
    Hüseyin Karaoğlan, Canan CAN, Nadiye Akdeniz, Duygu Has Simşek, Yunus Güzel, Berat Soylu, Ferat Kepenek, İhsan Kaplan, Serkan Kuyumcu, Fatih Güzel et al. · 2026 · Nuclear Medicine Communications
90. Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
    Hong-Yu Shen, Jin Zhang, Di Xu, Zheng Xu, Ming‐Xing Liang, Wenquan Chen, Jinhai Tang, Wenjia Xia · 2023 · Medicine
91. Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutations
    Yunyi Li, Zhihui Yang, Fang Wu, Qingchun Liang, James Gordon Herman, Malcolm V. Brock, Wenliang Liu, Fenglei Yu, Xue He, Chen Chen · 2025 · Clinical Epigenetics
92. Usual Lung Cancers
    Lucian R. Chirieac, Richard Luther Attanoos · 2018 · Elsevier eBooks
93. Development and validation of a nomogram based on preoperative variables for predicting recurrence‐free survival in stage IA lung adenocarcinoma
    Jiaxi Xu, Hui Zeng, Guochao Zhang, Renda Li, Zhenlong Yuan, Jingyu Ren, Yufei Huang, Fangzhou Ren, Hao Zhang, Kailun Fei et al. · 2023 · Thoracic Cancer
94. The Use of a Novel Immunohistochemical Triple Cocktail in the Subclassification of Resected Non–Small Cell Lung Carcinomas: A Comparative Study With Morphology and Traditional Immunohistochemistry
    Kim HooKim, Catherine S. Chaudoir, Shabnum Chaudhery, Michelle Dian Reid · 2016 · Applied immunohistochemistry & molecular morphology
95. Pathology and Molecular Pathology of Lung Cancer
    Lucian R. Chirieac, Lester Kobzik · 2016 · Springer eBooks
96. Epidermal growth factor receptor and v-Ki-ras2 Kirsten rat sarcoma viral oncogen homologue-specific amino acid substitutions are associated with different histopathological prognostic factors in resected non-small-cell lung cancer
    Joseph Seitlinger, Stéphane Renaud, Pierre‐Emmanuel Falcoz, Mickaël Schaeffer, Anne Olland, Jérémie Reeb, Nicola Santelmo, Michèle Legrain, Anne‐Claire Voegeli, Noëlle Weingertner et al. · 2016 · Interactive Cardiovascular and Thoracic Surgery
97. Microinvasive segmentectomy in a sculpting manner: a case of VATS left S1+2 segmentectomy
    Liang Xue, Yunfeng Yuan · 2017 · Journal of Thoracic Disease
98. Expression Level of Wnt5a Was Related to the Therapeutic Effects of First-Generation EGFR-TKIs
    Hai Zhang, Xiaohua Yang, Fang Hu, Changhui Li, Jianlin Xu, Wei Nie, Yinchen Shen, Yuqing Lou, Baohui Han, Hua Zhong et al. · 2020 · OncoTargets and Therapy
99. Uniportal video-assisted thoracoscopic surgery for lung cancer—current practices and outcomes: a narrative review
    Félix H. Savoie-White, Charles Antoine Menier, Arthur Vieira, Paula Antonia Ugalde · 2022 · Current Challenges in Thoracic Surgery
100. Video-Assisted Thoracic Surgery and Anatomical Lung Resections. Where Do We Stand? National Survey by the Spanish Society of Thoracic Surgery
     Raul Embun, Néstor J. Martínez Hernández, Sergi Call, Beatriz de Olaiz Navarro, Jon Zabaleta, Ricard Ramos, Jose Marcelo Galbis, Nicolás Moreno‐Mata · 2017 · Cirugía Española (English Edition)